The levels of DNMT-1, -3a, and -3b are generally upregulated in sporadic breast cancer and correlates with a poor prognosis; elevated DNMT1 level associates with lymph node metastasis, while DNMT3a and DNMT3b are associated with aggressive stages [55]. Here, DNMT1 is linked to metastatic malignant neoplasm in the lymph nodes.